There is good news from Virginia when it comes to the deadly infection sepsis.

“This is truly a groundbreaking discovery,” said Jianjie Ma, a professor in the department of surgery at the University of Virginia. “Sepsis is a very challenging disease to treat.”

Ma is part of the team at U.Va., along with the University of Michigan, that has developed a monoclonal antibody to stop sepsis . The deadly infection impacts up to 50 million people worldwide every year, killing about 11 million people, according to researchers. It’s the leading cause of death in U.S. hospitals.

“It’s a really urgent matter in the hospital, because when patients are admitted to the hospital, they have to be treated right away,” he said. “Any delay, one hour delay will cost 5% to 10% chance of people dying.”

U.

See Full Page